Antimicrobial peptides: review of their application in musculoskeletal infections

Hein P Stallmann1, Chris Faber, Arie V Nieuw Amerongen

  • 1Department of Orthopedic Surgery / VU University Medical Center, Amsterdam, The Netherlands.

Injury
|May 3, 2006
PubMed

Insights

Antimicrobial peptides (AMPs) show promise for treating osteomyelitis, even resistant strains. Local drug delivery systems effectively reduced bone infections in animal models, suggesting clinical potential.

Area of Science:

  • Infectious Diseases
  • Biochemistry
  • Pharmacology

Background:

  • Antimicrobial resistance (AMR) poses a growing threat to osteomyelitis treatment.
  • Novel therapeutic strategies are urgently needed to combat resistant bacterial infections.
  • Antimicrobial peptides (AMPs) represent a promising new class of antibiotics with unique properties.

Purpose of the Study:

  • To review the potential of antimicrobial peptides (AMPs) as a novel therapeutic approach for osteomyelitis.
  • To evaluate drug-release systems for local AMP delivery in treating bone infections.
  • To discuss the diagnostic and therapeutic applications of AMPs in bone and soft-tissue infections.

Main Methods:

  • Design and testing of degradable and nondegradable drug-release systems for AMPs.
  • Evaluation of AMP-loaded systems in animal models of osteomyelitis.
  • Review of systemic AMP applications, including diagnostic imaging with radioactive-labeled peptides.

Main Results:

  • AMP-based drug-release systems effectively reduced bone infections in animal models, targeting both resistant and non-resistant bacterial strains.
  • Radioactive-labeled AMPs demonstrated accuracy in differentiating sterile inflammation from active infection in imaging studies.
  • Preclinical data support the clinical evaluation of AMPs as potent antimicrobial agents.

Conclusions:

  • Antimicrobial peptides offer a potential solution to the increasing challenge of antimicrobial resistance in osteomyelitis.
  • Local delivery systems enhance AMP efficacy for bone infections, with promising preclinical results.
  • AMPs hold significant potential for both diagnosis and treatment of bone and soft-tissue infections, warranting clinical investigation.

Related Concept Videos

Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...